scispace - formally typeset
Open AccessJournal ArticleDOI

Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation.

Reads0
Chats0
TLDR
It is shown that MetAP-2 can be tethered to SCFβ-TRCP, ubiquitinated, and degraded in a Protac-1-dependent manner, which may be useful for conditional inactivation of proteins, and for targeting disease-causing proteins for destruction.
Abstract
The intracellular levels of many proteins are regulated by ubiquitin-dependent proteolysis. One of the best-characterized enzymes that catalyzes the attachment of ubiquitin to proteins is a ubiquitin ligase complex, Skp1-Cullin-F box complex containing Hrt1 (SCF). We sought to artificially target a protein to the SCF complex for ubiquitination and degradation. To this end, we tested methionine aminopeptidase-2 (MetAP-2), which covalently binds the angiogenesis inhibitor ovalicin. A chimeric compound, protein-targeting chimeric molecule 1 (Protac-1), was synthesized to recruit MetAP-2 to SCF. One domain of Protac-1 contains the IκBα phosphopeptide that is recognized by the F-box protein β-TRCP, whereas the other domain is composed of ovalicin. We show that MetAP-2 can be tethered to SCFβ-TRCP, ubiquitinated, and degraded in a Protac-1-dependent manner. In the future, this approach may be useful for conditional inactivation of proteins, and for targeting disease-causing proteins for destruction.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Small molecule recognition of disease-relevant RNA structures

TL;DR: This review highlights recent advances in this area, with a focus on the design of small molecule probes that selectively engage structures within disease-causing RNAs, with micromolar to nanomolar affinity, and explores emerging RNA-target strategies that allow for the targeted degradation of RNAs with impressive potency and selectivity.
Journal ArticleDOI

Conditional control of fluorescent protein degradation by an auxin-dependent nanobody

TL;DR: This work combines the advantages of auxin and nanobody-based degradation technologies creating an AID-nanobody to degrade GFP-tagged proteins at different cellular structures in a conditional and reversible manner in human cells.
Journal ArticleDOI

Bivalent Ligands for Protein Degradation in Drug Discovery.

TL;DR: A comprehensive overview of recent developments in the field of small molecule mediated protein degradation, including transcription factors, kinases and nuclear receptors is provided.
Journal ArticleDOI

Cancer Selective Target Degradation by Folate-Caged PROTACs.

TL;DR: In this paper, a cancer cell selective delivery strategy for PROTACs was developed by conjugating a folate group to a ligand of the VHL E3 ubiquitin ligase, to achieve targeted degradation of proteins of interest (POIs) in cancer cells versus noncancerous normal cells.
Journal ArticleDOI

Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction.

TL;DR: The discovery and characterization of NHWD-870 is reported, a BET inhibitor that is more potent than three major clinical stage BET inhibitors BMS-986158, OTX-015, and GSK-525762, and it is shown that it suppresses BRD4 and targets tumour associated macrophages.
References
More filters
Journal ArticleDOI

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

TL;DR: Recent progress has been made in understanding the details of the signaling pathways that regulate NF-kappaB activity, particularly those responding to the proinflammatory cytokines tumor necrosis factor-alpha and interleukin-1.
Journal ArticleDOI

IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation

TL;DR: In this article, a large multiprotein complex, the IkappaB kinase (IKK) signalsome, was purified from HeLa cells and found to contain a cytokine-inducible IKK kinase activity that phosphorylates IappaB-alpha and IKK-beta.
Journal ArticleDOI

SCF and Cullin/RING H2-Based Ubiquitin Ligases

TL;DR: This review is focused on a conserved ubiquitin ligase complex known as SCF that plays a key role in marking a variety of regulatory proteins for destruction by the 26S proteasome.
Journal ArticleDOI

Transduction of full-length TAT fusion proteins into mammalian cells:TAT-p27Kip1 induces cell migration

TL;DR: Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27 Kip1 induces cell migration and promotes cell migration in mice.
Journal ArticleDOI

Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity

TL;DR: In this article, the authors used biotinylated-epoxomicin as a molecular probe and showed that it covalently binds to the LMP7, X, MECL1, and Z catalytic subunits of the proteasome.
Related Papers (5)